Shareholders Equity ratio Analysis of MoonLake Immunotherapeutics - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointShareholders Equity of MLTX
Dec-2394.14Excellent Shareholders Equity | Dec-2263.63Very Good Shareholders Equity | Growth47.94% |
Shareholders Equity Analysis of MoonLake Immunotherapeutics
| Shareholder to Equity Ratio of MoonLake Immunotherapeutics with value of 94.14 indicates that shareholders own a High proportion of the assets of the company. |
| Shareholders Equity Ratio of MLTX rose handsomely by 47.94 % this year. |
Other Shareholders Equity Related Info of MLTX that may interest you.
MoonLake Immunotherapeutics Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MLTX | 40.17 | 41.41 | 2.99 % | Biotechnology |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..
Shareholders Equity Related Ratios
| DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
| Mild Stability | |
FY - Historical Shareholders Equity of MoonLake Immunotherapeutics
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| Shareholders Equity | 94.14 | 63.63 | -120.27 | 96.44 |
| Change | 47.94 % | 152.91 % | -224.71 % |
FY Chart of Shareholders Equity of MoonLake Immunotherapeutics
Note : All Data Generated at the End of Trading Hours (EOD Data)